Find trending articles through Social News Discovery®! Providing a collaboration of news through social media technologies.
Follow your friends and create your own Online Social Newspaper! Invite your friends to follow you from Facebook. Filter the news articles you see by section, clipper, or mood. Rate each article and comment on all news clips!
Receive site and email notifications about comments and news clips that you are collaborating on!
Get the latest news on the Everyone page, the viral and trending news clips will always be at the top! See the trending news and articles!
"The door remains open for Swiss pharmaceutical company Novartis to reach a deal with Colombia to lower the cost of cancer drug imatinib and prevent the Andean country from allowing generic production of the medication, the health minister said.", in.reuters.com
"Health Minister Alejandro Gaviria's remarks are the strongest yet in a fight with the world's biggest drugmaker. The Colombian Embassy described intense lobbying pressure on Colombia, a staunch U.S. ally, from the pharma industry and its allies in the U.S. Congress. Gaviria said the pressure shows the forceful steps that big pharma is willing to take to protect its commercial interests. 'They're very afraid that Colombia could become an example that spreads across the region,' he said.", www.allgov.com
"A showdown with the Swiss drugmaker is testing Colombia's progressive new healthcare reforms. An ambitious healthcare reform in Colombia may be facing its toughest challenge yet: the pharmaceutical industry. In a bold step with wide repercussions for Latin America’s healthcare sector and drug patent law, Colombia’s Ministry of Health in late April moved to unilaterally end Swiss drug giant Novartis’ patent on the expensive cancer treatment Glivec after the company refused to sell it at lower cost. This would be the country's first-ever “compulsory license,” which is when a government allows generic drug production without consent from the patent owner. ", www.as-coa.org
"FILE - In this Feb. 3, 2016, file photo, Colombia's Health Minister Alejandro Gaviria, center, speaks during a press conference after attending the summit to address the spread of Zika virus in the region, at the Mercosur building in Montevideo, Uruguay. On Tuesday, May 17, 2016, Gaviria gave pharmaceutical giant Novartis a few weeks to lower prices on a popular cancer drug or see its monopoly on production of the medicine broken and competition thrown open to generic rivals. (AP Photo/Matilde Campodonico, File)", www.dailytribune.net
Please enjoy the site during our beta phase and provide us with feedback on suggestions and issue details. Please remember that we are still in beta and there will be issues and site changes during this time.
Newsclip® the leading Online Social Newspaper, find trending articles through Social News Discovery®!
You can reopen the "Getting Started Tutorial" dialog from within the About menu in the top right corner.